8.14 USD
▼-0.18-2.16%
盘后 9.02 0.00%
2026-11-19
市值
$779.89M
市盈率
9.19
EPS
0.87
股息率
—
52 周区间
6.62 – 15.35
成交量
964.92K
Beta
1.07
目标价
27.75
52W 低 6.6252W 高 15.35
价格走势
公司简介
MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also develops AAV-AQP1 for radiation-induced grade 2/3 radiation-induced xerostomia, as well as for Sjogren’s syndrome; AAV-GAD in Phase 2 trial for Parkinson’s disease; AAV-RPE65 in Phase 2 trial for RPE65-associated retinal ...